tirzepatide surgery risk Bariatric vs. GLP-1 Medications: What the Latest Research Shows Evaluation of safety of preoperative

GLP1-RAs is clinically used to treat T2DM and promote weight loss in obese individuals

doi: 10.1186/s12933-022-01604-7, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 6

Quick recap of why this matters on semaglutide Semaglutide, available in India as Obeda (Dr Reddys Laboratories, launched March 2026) and as Ozempic, is a GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and drives significant weight loss

There is a tingling sensation throughout the injection process, there may be a slight pain

Not ideal for Patients likely to reach high doses

While these complications are uncommon, recognizing them quickly ensures timely intervention and prevents serious complications